Acadian Asset Management
AUPH icon

Acadian Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Acadian Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$631K Buy
37,363
+25,952
+227% +$415K ﹤0.01% 1381
2026
Q1 		$169K Buy
11,411
+1,803
+19% +$26.4K ﹤0.01% 1630
2025
Q4 		$152K Buy
+9,608
New +$136K ﹤0.01% 1588
2024
Q4 		– Sell
-8,732
Closed -$64K – 1642
2024
Q3 		$64K Buy
+8,732
New +$54.1K ﹤0.01% 1735

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management's AUPH Position: Q2 2026 in Review

Acadian Asset Management increased its Aurinia Pharmaceuticals (AUPH) stake by 227% in Q2 2026, buying an estimated $415K and bringing the position to 37,363 shares worth $631K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Acadian Asset Management first reported a position in AUPH in Q3 2024 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Acadian Asset Management held 37,363 shares of Aurinia Pharmaceuticals worth $631K as of Q2 2026.
  • Acadian Asset Management bought 25,952 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $415K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1381 holding.
  • Acadian Asset Management first reported a position in Aurinia Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.